Showing results (891-900 of 993) with videos related to

Sort By:
Pageof 100
British Journal of Cancer|July 17, 1998
Phase I study of the mitomycin C analogue BMS-181174V M Macaulay, K J O'Byrne, J A Green, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tractJ P Braybrooke, K J O'Byrne, M P Saunders, et al.
British Journal of Cancer|August 23, 2012
Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trialsA Giatromanolaki, M I Koukourakis, E Sivridis, et al.
Oncology Research|May 9, 2001
Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequenceS A Kakolyris, L G Kaklamanis, M J Koukourakis, et al.
Histopathology|June 26, 2003
The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical studyM Stewart, H Turley, N Cook, et al.
Oncogene|November 29, 2011
Igf2 ligand dependency of Pten(+/-) developmental and tumour phenotypes in the mouseD N Church, B R Phillips, D J Stuckey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosisM Ellis, D Spence, B de Pauw, et al.
British Medical Journal (Clinical Research Ed.)|November 28, 1981
Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trialI E Smith, A L Harris, M Morgan, et al.
Cancer Research|August 28, 2001
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervixJ A Loncaster, A L Harris, S E Davidson, et al.
British Journal of Cancer|May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancerO A Khan, A D Blann, M J Payne, et al.
Pageof 100